1. P534: AZACITIDINE PLUS VENETOCLAX FOR THE TREATMENT OF RELAPSED AND FIRST-LINE AML PATIENTS. (23rd June 2022) Authors: Garciaz, S.; Hospital, M.-A.; Alary, A.-S.; Saillard, C.; Hicheri, Y.; Mohty, B.; Rey, J.; D'incan, E.; Charbonnier, A.; Ferdinand, V.; Maisano, V.; Lombardi, L.; Ittel, A.; Mozziconacci, M.-J.; Gelsi-Boyer, V.; Vey, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PB1810: OUTCOME OF ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENIC STEM CELL TRANSPLANT: A SINGLE INSTITUTION RETROSPECTIVE STUDY. (23rd June 2022) Authors: Castoldi, C.; Hicheri, Y.; Devillier, R.; Hospital, M.-A.; D'Incan, E.; Garciaz, S.; Maisano, V.; Saillard, C.; Rey, J.; Granata, A.; Harbi, S.; Legrand, F.; Furst, S.; Blaise, D.; Vey, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III: EFFICACY OF CPX-351 AS FIRST LINE TREATMENT FOR HIGHER RISK (HR) MDS/CMML. A STUDY BY THE GFM. (September 2021) Authors: Peterlin, P.; Turlure, P.; Chevallier, P.; Gourin, M.-P.; Dumas, P.-Y.; Thepot, S.; Berceanu, A.; Park, S.; Hospital, M.-A.; Cluzeau, T.; Torregrossa-Diaz, J.-M.; Devron, L.; Sapena, R.; Chermat, F.; Dimicoli-Salazar, S.; Fenaux, P. Journal: Leukemia research Issue: Volume 108(2021)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗